A carregar...
Defining the right diluent for intravenous infusion of therapeutic antibodies
Therapeutic monoclonal antibodies (mAbs) are commonly administered to patients through intravenous (IV) infusion, which involves diluting the medication into an infusion solution (e.g., saline and 5% dextrose). Using the wrong diluent can cause product aggregation, which may compromise patient safet...
Na minha lista:
| Publicado no: | MAbs |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Taylor & Francis
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6927757/ https://ncbi.nlm.nih.gov/pubmed/31774346 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/19420862.2019.1685814 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|